Written by: Andy Russell, Vice President, Growth & Product Strategy at RxE2The San Diego Signal: An Industry Carrying a Heavy Load There was a moment coming out of GCSG this year where something started to feel different. Not because we suddenly discovered new problems. We didn’t. If anything, the industry showed just how well it…
The recent 2026 U.S. Annual Conference of the Global Clinical Supplies Group in San Diego felt different than previous years. In the past, these gatherings often focused on the promise of distant technologies or abstract innovations. However, the tone this year was grounded in a heavy sense of pragmatism. Leaders from the largest pharmaceutical organizations…
Welcome to our E2 Dispensing Webinar series. Over the next few weeks, we will release 8 episodes, introducing the E2 dispensing methodology and ecosystem to all. These webinars are aimed at everyone involved in clinical research and clinical trials. We will go into RxE2’s innovative and disruptive way of simplifying decentralized clinical trials and more specifically introducing…
By: Gerald E. Finken Originally posted on Linkedin In November 2021, McKinsey & Company published an interesting article on how to boost excellence and innovation in clinical supply chains that are relevant to today’s industry practices. What I found most compelling was how a best-in-class clinical supply chain could change and adapt to accommodate decentralized clinical trials (DCTs)…
By: Gerald E. Finken Originally posted on Linkedin Being a pharmacist has always given me a unique insight into healthcare, especially as my career took me into the packaging and labeling of clinical supplies. I was always able to think about the packaging and labeling of clinical supplies from a different perspective, both as a…
By: Gerald E. Finken The introduction of decentralized clinical trials (“DCTs”) into clinical research has, in recent years, focused on the use of technology and telehealth to improve the clinical trial experience for patients. The proponents of the DCT model have heralded it, and rightly so, with improving study recruitment, providing better patient diversity, and…